News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
PreveCeutical Medical Announces Frontiers Media SA Publication Featuring Data from its Analgesic Program for the Treatment of Peptide-based Therapeutics for Moderate to Severe Pain
April 4, 2023
·
6 min read
BioHarvest Sciences Announces Major Media Campaign to Focus on VINIA Real Stories
April 4, 2023
·
5 min read
StageZero Life Sciences, Ltd Announces Q4 2022 and Year End Financial Results and Operational Update
April 3, 2023
·
5 min read
Business
Hemostemix’ Second Round Interviews with Executive Vice President Business Development Candidates
April 3, 2023
·
8 min read
Solarvest Reports Second Quarter Fiscal 2022 Financial Results
March 31, 2023
·
4 min read
NovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports 2022 Results on Form 10-K
March 31, 2023
·
2 min read
Satellos Bioscience Announces 2022 Year End Financial Results and Operational Highlights
March 31, 2023
·
10 min read
StageZero to Issue Q4 2022 Financial Results on Friday March 31
March 30, 2023
·
2 min read
Satellos Bioscience Announces Closing of Previously Announced Non-Brokered Offering of $2.385 Million of Unsecured Non-Convertible Debentures
March 30, 2023
·
7 min read
StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30
March 30, 2023
·
2 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us